Aldesleukin Terminated Phase 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00784524Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca